We assessed incidence and predictors of hyperkalemia ( potassium @ mmol/L ) and hypokalemia ( potassium < @ mmol/L ) and the relationship to outcomes in @ patients with class III or IV heart failure and left ventricular ejection fraction < @ % randomized to treatment with spironolactone @ mg or placebo in the Randomized Aldactone Evaluation Study ( RALES ) trial .